Impact of concomitant mesalazine administration on the efficacy and safety of advanced therapies in ulcerative colitis: a meta-analysis over the induction and maintenance phases
Abstract
Meta-analysis of RCTs in adults with moderate-to-severe ulcerative colitis evaluating whether concomitant mesalazine (5-ASA) use affects efficacy (clinical/endoscopic outcomes) and safety during induction and maintenance of approved biologics and small molecules.
Fields of Study & Subjects
Inflammatory Bowel Disease
Rheumatoid Arthritis Research and Therapies
Microscopic Colitis
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint